# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Autoimmune Diseases

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 1713 results.
Trial Assessing Safety and Efficacy of Gammanorm® in Autoimmune Diseases
Status: Recruiting
Last Changed: Sep 09, 2019
First Received: Sep 03, 2018
Disease(s): Autoimmune Diseases
Intervention(s): Gammanorm
Locations: APHP - Pitie Salpetriere, Paris, France
Chu de Rouen - Bois Guillaume, Rouen, France
CHU de la Martinique- Hopital Pierre Zobda Quitman, Fort-de-France, Martinique
Alternative Care in Patients With Auto‐Immune Diseases
Status: Not yet recruiting
Last Changed: Sep 18, 2019
First Received: Sep 18, 2019
Disease(s): Auto‐Immune Diseases
Intervention(s): Questionnaire.
Study of Infections in Patients With Autoimmune Diseases Treated With Rituximab
Status: Not yet recruiting
Last Changed: May 29, 2019
First Received: Dec 18, 2018
Disease(s): Autoimmune Diseases
Patient-Reported AutoImmunity Secondary to Cancer immunothErapy
Status: Not yet recruiting
Last Changed: Feb 21, 2019
First Received: Feb 21, 2019
Disease(s): Opportunistic Autoimmune Diseases
Intervention(s): Biological collection
EBMT ADWP Prospective Non-interventional Study: Post-AHSCT Management in SSC Patients (NISSC-2)
Status: Recruiting
Last Changed: Sep 02, 2019
First Received: Feb 23, 2018
Disease(s): Autoimmune Diseases
Intervention(s): Autologous HSCT
Locations: Badoglio Manuela- EBMT Paris Office, Paris, France
Trauma as a Trigger for Autoimmunity
Status: Recruiting
Last Changed: Dec 07, 2018
First Received: Dec 07, 2018
Disease(s): Induction of Autoimmunity
Intervention(s): Comparison of the levels of antinuclear antibodies (ANA) by indirect immunofluorescence on a Hep-2 cell line.
Locations: University Hospital Basel, Basel, Switzerland
Endometrial Markers in Autoimmune Diseases
Status: Not yet recruiting
Last Changed: Feb 15, 2019
First Received: Feb 15, 2019
Disease(s): Endometrial Receptivity, Fertility, Autoimmune Diseases
Intervention(s): Measure endometrial markers
Documentation of the Safety and Effectiveness Profile of the IgG Immunoadsorbers GLOBAFFIN® and LIGASORB® and IgE Immunoadsorber IgEnio® in Clinical Routine (SEPIAR)
Status: Recruiting
Last Changed: Sep 10, 2019
First Received: Sep 05, 2019
Disease(s): Autoimmune Diseases
Intervention(s): Immunoadsorbers GLOBAFFIN®, LIGASORB® and IgEnio®
Locations: Städtisches Klinikum Braunschweig, Braunschweig, Niedersachsen, Germany
Diakonissenkrankenhaus Flensburg, Flensburg, Germany
Diagnostic and Imaging Indicators of Immunocardiomyopathic Patients
Status: Recruiting
Last Changed: Mar 21, 2019
First Received: Mar 21, 2019
Disease(s): Autoimmune Diseases
Locations: Peking Union Medical College Hostipal, Beijing, Beijing, China
Leflunomide Treatment for IgG4-RD
Status: Recruiting
Last Changed: Oct 23, 2018
First Received: Oct 23, 2018
Disease(s): Autoimmune Disease
Intervention(s): Prednisone, Prednisone and Leflunomide
Locations: Yunyun Fei, Beijing, Beijing, China